The Joe Rogan ExperienceJoe Rogan Experience #2357 - Sarko Gergerian
CHAPTERS
- 0:00 – 2:11
Meeting via Paul Stamets & safety tensions at Psychedelic Science conferences
Joe opens by asking how Sarko met Paul Stamets and what brought him to Psychedelic Science. Sarko describes being invited to help attendees feel safe amid heightened political sensitivities and the potential for emotionally charged disruptions.
- •How Sarko connected with Paul Stamets
- •Why conference organizers worried about protests/disruptions
- •Balancing open dialogue with maintaining safety at events
- •Reference to Rick Doblin handling a prior on-stage disruption
- 2:11 – 3:00
A cop, a therapist, and a first-of-its-kind religious exemption for entheogens
Sarko explains his professional identity: a Massachusetts law enforcement lieutenant who is also a therapist trained in psychedelic-assisted work. He notes the unusual (and precedent-setting) nature of obtaining a workplace religious exemption to access entheogens.
- •Law enforcement career and rank
- •Clinical/therapeutic training alongside policing
- •Religious exemption as a pathway to lawful entheogen access
- •Why his background is atypical in policing circles
- 3:00 – 5:06
From religion & philosophy studies to witnessing MDMA reshape club culture
Sarko traces his early “seeker” path through Northeastern University, shifting from behavioral psychology into religion and philosophy. While working nightclub security in 1990s Boston, he watched MDMA transform social behavior and club dynamics in real time.
- •Undergrad shift from psychology to religion/philosophy
- •Co-op work as nightclub security in Boston
- •First-hand observation of ecstasy/MDMA changing crowd behavior
- •Early seeds of curiosity about entheogens and culture
- 5:06 – 7:53
The turning point: Rick Doblin’s MDMA/PTSD presentation at the Chiefs of Police conference
As a cop and therapist attending the IACP conference, Sarko sees Rick Doblin present MAPS’ MDMA-assisted psychotherapy data for severe, treatment-resistant PTSD. The striking efficacy figures—and the fact that most attendees chose to see Donald Trump instead—solidified Sarko’s commitment to help.
- •IACP conference context and law-enforcement audience
- •Phase 2 MDMA-assisted psychotherapy PTSD outcomes
- •How Doblin framed the prep–session–integration model
- •Sarko’s immediate impulse to get involved and train
- 7:53 – 9:18
MAPS training, a filmed ‘mystical experience,’ and the roadblock at the FDA
Sarko describes joining early MDMA-assisted therapy training and participating in a federally sanctioned protocol so therapists understand the medicine experientially. He recounts his filmed MDMA session featured in How to Change Your Mind and then pivots to frustration over the FDA advisory committee delay.
- •Why therapist experiential training was considered important
- •Sarko’s MDMA experience and its personal impact
- •Appearance in Michael Pollan’s docuseries
- •FDA advisory committee delay and calls for another Phase 3 trial
- 9:18 – 21:20
First-responder trauma, suicide, and the ‘muzzle’ inside law enforcement culture
The discussion turns to why psychedelics matter urgently for police: high trauma exposure and elevated suicide rates. Sarko argues that officers are culturally and institutionally discouraged from speaking about or pursuing psychedelic healing, pushing many toward alcohol abuse or silence until crisis.
- •Suicide rates among police vs civilians
- •Cumulative critical-incident exposure and nervous system effects
- •Career risk and stigma that suppress open discussion
- •Moral injury and the hidden costs of ‘just deal with it’ culture
- 21:20 – 29:39
Safe supply, prohibition logic, and why drug policy ‘hijacks’ policing
Joe and Sarko connect today’s illicit drug risks (fentanyl adulteration, cartel violence) to the predictable outcomes of prohibition, using alcohol prohibition as a historical parallel. Sarko argues the war on drugs shifts policing away from protecting rights and toward serving profit-driven systems.
- •Illicit markets, fentanyl contamination, and preventable deaths
- •Prohibition’s predictable incentives and cartel power
- •Policing vs public health: what enforcement actually harms
- •Cannabis arrests, racial impacts, and moral injury for officers
- 29:39 – 44:34
Why cannabis was criminalized: Hearst, propaganda, and suppressing hemp as a commodity
Joe lays out the historical argument that early cannabis prohibition was driven less by public safety than by economic interests threatened by hemp’s industrial potential. They discuss the decorticator, ‘marijuana’ branding, and propaganda campaigns that leveraged racism and fear.
- •Hemp as superior textile/paper and the decorticator’s impact
- •Hearst/Anslinger-era propaganda and ‘Reefer Madness’
- •How public fear campaigns shaped policy for decades
- •Economic incentives: threats to paper mills, timber, and industry
- 44:34 – 1:00:40
Medicine, spirituality, and a broader definition of healing (Western science + Indigenous wisdom)
Sarko challenges rigid Western definitions of “medicine,” arguing for room to include community, joy, and indigenous knowledge alongside clinical evidence. They discuss how psychedelic prohibition historically served control structures and how access might expand creativity, meaning, and spiritual engagement.
- •‘Who gets to define medicine?’ and why that matters
- •Paul Stamets’ “two eyes” framing: science + indigenous wisdom
- •Psychedelics as a catalyst for cultural creativity and meaning
- •Historical suppression of mystical practices and modern parallels
- 1:00:40 – 1:46:22
Ketamine, harm reduction, and everyday drug hypocrisies (caffeine, nicotine, Coca-Cola)
Sarko shares personal experiences with ketamine and discusses its rapid effects on suicidality and depression, while acknowledging addiction risks and misuse. The conversation broadens into culturally accepted stimulants—caffeine and nicotine—and the surprising history of cocaine in Coca-Cola as an example of shifting norms.
- •Sarko’s ketamine experience and dissociation framework
- •Addiction/misuse risks and the need for education
- •Caffeine/nicotine normalization vs stigma toward psychedelics
- •Cocaine in early Coca-Cola and modern regulatory contradictions
- 1:46:22 – 1:52:23
Legalization vs decriminalization: the Portland/Oregon cautionary tale and what ‘doing it right’ requires
Joe raises Oregon’s decriminalization rollout as an example of policy going sideways without structure, enforcement of basic public-order rules, or adequate treatment systems. Sarko agrees decriminalization must be paired with regulation, clear boundaries (e.g., not allowing public camping/using everywhere), and wraparound services including safe-use facilities.
- •Why Oregon became a go-to destination for visible street use
- •Distinguishing decriminalization from ‘anything goes’
- •Need for rules, sanitation, and public-space standards
- •Safe injection/safe supply models and the importance of proper implementation
- 1:52:23 – 1:57:22
A workable model: Winthrop’s CLEAR program linking police to public health & recovery
Sarko describes building a follow-up model where officers revisit overdose and mental-health-related calls to connect people to help rather than default to enforcement. He explains how CLEAR (Community and Law Enforcement Assisted Recovery) created a pipeline between police and public health, reframing policing as guardianship plus accountability.
- •How Sarko identified recurring public-health issues in police logs
- •Door-knocking follow-ups focused on needs, not arrests
- •Partnership with public health and peers with lived experience
- •CLEAR as a scalable model: recovery-oriented community policing
- 1:57:22 – 1:59:37
Closing: how to contact Sarko & final reflections on speaking out
Joe wraps by acknowledging Sarko’s willingness to publicly discuss taboo topics within law enforcement culture. Sarko shares where people can find him, clarifies he’s speaking for himself (not his department), and offers direct contact info for follow-up.
- •Where to find Sarko online and how to email him
- •Disclaimer about speaking personally vs representing his department
- •Joe’s praise for courage and advocacy
- •Final shout-out and sign-off
